• Blog
    July 29, 2026

    The pharmaceutical technology market is moving beyond point solutions. For years, providers competed by solving specific problems within individual parts of the value chain. Today, differentiation increasingly depends on how well those solutions can understand context,…
  • Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Technology Awareness Deep Dive
    July 20, 2026

    This report provides Everest Group’s assessment of the emerging world model technology landscape, including its core subsegments, maturity trajectory, enterprise adoption potential, and competitive implications. It examines how world models are evolving into integrated systems stacks…
  • Provider Recognition
    July 15, 2026

    Pharmaceutical enterprises are accelerating technology investments to modernize operations across the pharmaceutical value chain spanning drug discovery, clinical development, manufacturing, sales and marketing, supply chain and distribution, and pharmacovigilance. As AI, cloud, and data-driven capabilities become…
  • Life Sciences commercial teams have a familiar problem: every few years, the industry finds a new way to create fragmentation.  First came Customer Relationship Management (CRM) add-ons. Then omnichannel tools, content platforms, analytics dashboards, field enablement systems, event platforms,…
  • Blog
    July 10, 2026

    A perspective on quantum computing as a service, platform risk, and practical investment discipline for enterprise adoption.  Reach out to discuss this topic in depth.   Quantum is becoming a technology management question  Quantum computing is moving from research topic to enterprise Technology -…
  • Blog
    July 08, 2026

    Artificial Intelligence (AI) is having its moment. After years of cautious skepticism, pilot-stage overhang, and boardroom debates, the conversation has moved beyond experimentation. Enterprises are no longer asking whether to deploy agents, they are now asking how fast they can scale them across their entire workflow estate. However, speed comes at a price and almost nobody is doing the math.   The warning signs…
  • R&D Strategic Technology Outlook
    June 25, 2026

    This report examines the emergence of Self-driving Labs (SDLs) as integrated experimental systems that combine automation, data infrastructure, orchestration platforms, and AI to autonomously design, execute, analyze, and iteratively refine experiments. It explores how SDLs are…
  • State of the Market
    June 22, 2026

    Life sciences enterprises are rethinking Customer Relationship Management (CRM) services as commercial transformation becomes more complex, platform-driven, and outcome-focused. As organizations migrate to cloud-based CRM environments, expand their Veeva and Salesforce ecosystems, and navigate increasingly complex…
  • For years, life sciences commercial technology providers sold nouns. Customer Relationship Management (CRM). Analytics. Content. Events. Patient engagement. Next-best-action. Learning. Field enablement.  Each category had its own buyer, its own implementation partner, its own operating model, and often its own dashboard.…
  • Technology Awareness Deep Dive
    May 25, 2026

    This report examines the evolution of neoclouds as AI-first infrastructure platforms designed to support large-scale AI training, inference, and data-intensive workloads. It explores how growing AI demand is reshaping cloud infrastructure economics, pushing enterprises toward GPU-centric,…
  • Emerging Technologies
    May 20, 2026

    Building enterprise-grade cybersecurity now requires more than strengthening defenses. Organizations must create adaptive, resilient, and trust-centric security architectures that continuously evolve against increasingly intelligent threats. Cybersecurity’s next era will depend on advancing protection, governance, and operational…
  • LinkedIn Live
    April 27, 2026

    Everest Group’s Isaac Premsingh, Research Director, Digital and Embedded Technologies, and Dr. Shalini Sharma, Ph.D., Semiconductor Product Leader, led the first session in the “In Conversation Series” on May 21, exploring how AI was accelerating closed-loop…
  • Tech Provider Spotlight
    March 19, 2026

    Life sciences commercial engagement is undergoing a fundamental transformation as enterprises move from siloed, channel-centric models to coordinated, customer-centric omnichannel strategies. Increasing Healthcare Professionals (HCP) access constraints, evolving customer expectations, proliferation of digital channels, and mounting…
  • Discovery
    March 17, 2026

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world's leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • LinkedIn Live
    March 03, 2026

    The new space economy was moving from exploration to economy. Advances in commercial launch, miniaturization, and digital engineering were turning orbit into a place not just to visit, but to build, manufacture, and operate. The opportunity…
  • Discovery
    March 02, 2026

    Discoveries focus on specific science and technology innovations that address today’s critical business issues and challenges. These brief yet detailed profiles highlight innovations across the world's leading companies, start-ups, universities, institutes, and the entire R&D ecosystem…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Feb. 04, 2026

    As the Veeva ecosystem continues to expand rapidly - now representing a market of nearly $2 billion- life sciences organizations are rethinking how they approach Veeva-enabled transformation. What was once focused primarily on implementation is evolving…
  • Video
    Feb. 03, 2026

    As Veeva becomes the cornerstone of strategic transformation in life sciences, expectations from service providers are rapidly evolving. In this Q&A session, Chunky Satija, Vice President, and Rohit K, Practice Director, from Everest Group, discuss the…

Items per page